Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- * Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology that provides a novel approach for rotator cuff augmentation designed for increased biomechanical strength. * The acquisition strengthens Stryker’s shoulder portfolio, enhancing its ability to support specialists across the continuum of care. * The FiberLocker System is a soft tissue augmentation technology designed to reduce the occurrence of a key clinical failure mode in rotator cuff repair, one of the fastest-growing segments in sports medicine. Stryker (NYSE:SYK), a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and developer of the FiberLocker(®) System. This commercialized technology provides a novel approach for rotator cuff augmentation with increased biomechanical strength to address a key clinical failure mode in rotator cuff repair.